-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Overweight on Compass Pathways, Lowers Price Target to $16

Benzinga·03/25/2026 17:37:13
Listen to the news
Morgan Stanley analyst Vikram Purohit maintains Compass Pathways (NASDAQ:CMPS) with a Overweight and lowers the price target from $18 to $16.